Androgen Responses to hCG and Ovarian Morphology in PCOS
NCT03489668 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2018-08-09
Summary
Rationale and Hypothesis We have previously reported that theca cells (TC) responses to hCG in women with PCOS represent a spectrum where some exhibit exaggerated increases of 17OHP while in others 17OHP responses resemble those of normal women (Maas KH et al, JCEM, 2015). The basis for this differential responsiveness is not clear. Earlier studies reported that 17OHP responses to gonadotropin stimulation were heterogeneous among PCOS women, which was attributed to the degree of hyperinsulinemia (Pasquali R et al, JCEM, 2007). However, assessment of the ovary was omitted in the analysis. In preliminary studies, we have found that in women with PCOS, insulin sensitivity was strongly correlated with insulin sensitivity index as assessed by the method of Matsuda and DeFronzo (Diabetes Care, 1999). However, the study lacked sufficient numbers. Further analysis of insulin sensitivity with respect to hCG stimulated theca cell responses is warranted.
We have also examined 17OHP responses to hCG in relationship to antral follicle count and anti-Müllerian hormone (AMH) in PCOS and normal women. In PCOS women, as expected, serum AMH correlated with antral follicle count. However, TC responses in PCOS were inversely related to AMH (Maas KH et al, JCEM, 2015). These novel observations suggested that in PCOS AMH production may reflect redistribution of the follicle population. In human ovaries maximal immunodetection of AMH is observed in small (\< 4 mm) antral follicles followed by a rapid and progressive decline until an absence of the protein by 8 mm (Weenen C et al, Mol Hum Reprod, 2004). This consideration raises the issue of whether normal AMH levels represent more advanced follicle growth in some PCOS women compared with that of others with elevated AMH levels. An increased stage of follicle development would be accompanied by increased TC hyperplasia and may account for greater 17OHP responses to hCG stimulation. A comparison of TC responses to hCG with ovarian morphology has not be done in women with PCOS.
Based on these findings, we hypothesize that in PCOS, heterogeneous TC responses to hCG reflect differences in morphometric development of the follicle population. In addition, the positive correlation between insulin sensitivity and TC responses to hCG suggest an effect of hyperinsulinemia. We propose to investigate the relationship between theca cell responses to hCG, follicle morphology, and insulin sensitivity before and following treatment with an insulin lowering drug, metformin.
Conditions
- PCOS
Interventions
- DRUG
-
MetFORMIN 500 Mg Oral Tablet
metformin administration 1500mg per day
Sponsors & Collaborators
-
University of California, San Diego
collaborator OTHER -
Poznan University of Medical Sciences
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 37 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-20
- Primary Completion
- 2020-01-31
- Completion
- 2020-03-31
Countries
- Poland
Study Locations
More Related Trials
-
Correlation of Insulin Resistance With Hormonal and Ovarian Morphological Characteristics in Patients With Polycystic Ovarian Syndrome
NCT05661565 ·Status: UNKNOWN
-
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
NCT00989781 ·Status: COMPLETED ·Phase: NA
-
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
NCT03316469 ·Status: UNKNOWN ·Phase: NA
-
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
NCT00364949 ·Status: COMPLETED
-
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
NCT03652987 ·Status: SUSPENDED
-
Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
NCT03483792 ·Status: COMPLETED
-
The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire
NCT01256970 ·Status: COMPLETED
-
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
NCT01927471 ·Status: COMPLETED
-
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
To Study Polycystic Ovary Syndrome in Taiwanese Women
NCT01256944 ·Status: COMPLETED
-
Oral Administration of DCI to Women With PCOS
NCT00497653 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Metabolic Disorders in Polycystic Ovarian Syndrome
NCT00172523 ·Status: UNKNOWN
-
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
NCT05555680 ·Status: TERMINATED
-
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
NCT03252223 ·Status: COMPLETED ·Phase: PHASE4
-
Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome
NCT03088046 ·Status: COMPLETED ·Phase: NA
-
the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome
NCT01752270 ·Status: UNKNOWN ·Phase: PHASE4
-
Adipokines in Polycystic Ovary Syndrome
NCT06793072 ·Status: RECRUITING
-
Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome
NCT01788215 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of a Prospective Cohort of Women With PCOS
NCT02010814 ·Status: RECRUITING
-
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297 ·Status: RECRUITING
-
Sebum Measurement in Newborn to Detect Hyperexposure to Androgens
NCT04065100 ·Status: UNKNOWN ·Phase: NA
-
Low Dose Growth Hormone in Obese PCOS Women
NCT00518635 ·Status: WITHDRAWN ·Phase: NA
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome
NCT01859663 ·Status: COMPLETED
-
Effects of Alpha-acid Lipoic in PCOS Women
NCT02666170 ·Status: UNKNOWN ·Phase: NA